The Role of Sodium-Glucose Cotransporter-2 Inhibition in Heart Failure with Preserved Ejection Fraction

Sodium-glucose cotransporter-2 (SGLT2) inhibitors are a novel class of antidiabetic mediations found to also reduce cardiovascular morbidity and mortality and hospitalization for heart failure. Positive results from the EMPEROR-Preserved (empagliflozin) and PRESERVED-HF (dapagliflozin) studies led t...

Descripción completa

Detalles Bibliográficos
Autores principales: Brust-Sisti, Lindsay, Rudawsky, Nicole, Gonzalez, Jimmy, Brunetti, Luigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788031/
https://www.ncbi.nlm.nih.gov/pubmed/36548322
http://dx.doi.org/10.3390/pharmacy10060166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788031/
https://www.ncbi.nlm.nih.gov/pubmed/36548322
http://dx.doi.org/10.3390/pharmacy10060166

Ejemplares similares